EcoDrugPlus

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSTBEG00000001420
Gene Symbol: PTPN11
1 Cross references
251 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSTBEG00000008980
Gene Symbol: PTPRB
1 Cross references
264 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSTBEG00000016378
Gene Symbol: PNP
1 Cross references
429 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSTBEG00000013709
Gene Symbol: P2RX3
1 Cross references
270 Possible Orthologues:

Purinergic Receptor P2x 7

Ensembl ID : ENSTBEG00000000881
Gene Symbol: P2RX7
1 Cross references
187 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSTBEG00000001501
Gene Symbol: P2RY4
1 Cross references
165 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSTBEG00000006239
Gene Symbol: RIPK1
1 Cross references
197 Possible Orthologues:

Renin

Ensembl ID : ENSTBEG00000014974
Gene Symbol: REN
1 Cross references
218 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSTBEG00000011269
Gene Symbol: RET
1 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSTBEG00000014225
Gene Symbol: RARB
1 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSTBEG00000015684
Gene Symbol: RARG
1 Cross references
445 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSTBEG00000015312
Gene Symbol: RXRB
1 Cross references
234 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).